Organization Overview
Timeline
Active Ingredients
Indications
Clinical Trials
Targets and Mechanisms
c-peptide (2 trials)
Diabetes Mellitus (Phase 2)
Diabetes Mellitus, Type 1 (Phase 2)
Diabetic Neuropathies (Phase 2)
Peripheral Nervous System Diseases (Phase 2)
Trials (2 total)
Trial APIs (1 total)